End-To-End Services: Discovery To Commercialization

Advancing biologics and cell therapy requires seamless integration across discovery, development, and commercialization. Global capabilities now enable efficient transitions through every stage, from antibody discovery and plasmid engineering to viral vector and mRNA manufacturing. Sophisticated platforms, such as single B-cell technologies and optimized cell line development systems, support innovation while reducing complexity. Large-scale GMP facilities provide flexibility for early clinical batches and commercial production, ensuring compliance and scalability. With proven experience in regulatory approvals and hundreds of successful GMP runs, these resources help accelerate timelines and minimize risk for developers.

Discover how comprehensive infrastructure and advanced technologies can streamline your path to market and drive success in next-generation therapies.